Skip to main content
Premium Trial:

Request an Annual Quote

Lifebit Biotech Raises £6M in Series A Funding Round

NEW YORK – Lifebit Biotech said Thursday that it has closed a £6 million ($7.5 million) Series A funding round. Idinvest Partners led the round, with participation from previous investors Pentech Ventures, Beacon Capital, and Connect Ventures. 

London-based Lifebit said that it will use the cash infusion to expand its market globally and to continue product development. 

The news follows on the heels of the firm's release of an update to its Lifebit CloudOS, a cloud-native, federated genomics operating system that functions as a managed service of individual clouds or high-performance computing centers to support analysis of bioinformatics data across sites and institutions. Notably, CloudOS version 2.0 integrates a new feature called Biobank Data Browser for querying large sets of structured omics, phenotypic, and clinical data from sources including the UK Biobank. 

"This financing comes at a pivotal time as we are rapidly expanding our global presence, accelerating product innovation, and continuing to grow our team of world-class engineers and bioinformaticians," Lifebit CEO Maria Chatzou Dunford said in a statement. "With our partners and customers, we are pushing forward the frontiers of health and creating a more integrated, accessible landscape of knowledge that enriches life and enables meaningful breakthroughs." 

The Scan

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.

Study Examines Relationship Between Cellular Metabolism, DNA Damage Repair

A new study in Molecular Systems Biology finds that an antioxidant enzyme shifts from mitochondria to the nucleus as part of the DNA damage response.

Stem Cell Systems Target Metastatic Melanoma in Mouse Model

Researchers in Science Translational Medicine describe a pair of stem cell systems aimed at boosting immune responses against metastatic melanoma in the brain.

Open Pediatric Brain Tumor Atlas Team Introduces Genomic Data Collection, Analytical Tools

A study in Cell Genomics outlines open-source methods being used to analyze and translate whole-genome, exome, and RNA sequence data from the Pediatric Brain Tumor Atlas.